基于流感发病机制的药物研究进展(6)
【作者】网站采编
【关键词】
【摘要】[1] Iuliano A D,Roguski K M,Chang H H,et of global seasonal influenza-associated respiratory mortality:A modelling study [J].Lancet,2018,391():1285-300. [2] 邹迁达,包佳琪,郑书发,等.流行性感
[1] Iuliano A D,Roguski K M,Chang H H,et of global seasonal influenza-associated respiratory mortality:A modelling study [J].Lancet,2018,391():1285-300.
[2] 邹迁达,包佳琪,郑书发,等.流行性感冒重症化机制研究及治疗进展 [J].医学研究杂志,2019,48(9):5-8,108.
[2] Zhou Q D,Bao J Q,Zhen S F,et and treatment progress of the mechanism of severe influenza [J].JMedRes,2019,48(9):5-8,108.
[3] Lian W,Fang J,Li C,et of influenza a virus neuraminidase inhibitors using support vector machine and Naive Bayesian models [J].MolDivers,2016,20(2):439-51.
[4]] Chen F,Liu T,Xu J,et al.Key amino acid residues of neuraminidase involved in influenza A virus entry [J].PathogDis,2019,77(6):63.
[5] Choi J G,Kim Y S,Kim J H,et activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition [J].SciRep,2019,9(1):121-32.
[6] Swamnathan K,Müller P,Downard K effects on the binding of natural product anthocyanidin inhibitors to influenza neuraminidase with mass spectrometry [J].AnalChimActa,2014,828:61-9.
[7] Zhou X,Li H,Shi Z,et activity of a traditional Chinese herbal formula Huang-Lian-Jie-Du-Tang and its major components found in its plasma profile on neuraminidase-1 [J].SciRep,2017,7(1):.
[8] Kadaw R U,Wilson I basis of influenza virus fusion inhibition by the antiviral drug Arbidol [J].ProcNatlAcadSciUSA,2017,114(2):206-14.
[9] Heo Y,Cho Y,Ju K S,et activity of Poncirus trifoliata seed extract against oseltamivir-resistant influenza virus [J].JMicrobiol,2018,56(8):586-92.
[10] Sencanski M,Radosevic D,Perovic V,et products as promising therapeutics for treatment of influenza disease [J].CurrPharmDesign,2015,21(38):5573-88.
[11] Gasparini R,Amicizia D,Lai P L,et with anti-influenza activity:Present and future of strategies for the optimal treatment and management of I:Influenza life-cycle and currently available drugs [J].JPrevMedHyg,2014,55(3):69-85.
[12] Hu Y,Sneyd H,Dekant R,et A virus nucleoprotein:A highly conserved multi-functional viral protein as a hot antiviral drug target [J].CurrTopMedChem,2017,17(20):2271-85.
[13] White K M,Abreu P,Wang H,et al.Broad spectrum inhibitor of influenza A and B viruses targeting the viral nucleoprotein [J].ACSInfectDis,2018,4(2):146-57.
[14] Zhou Z,Liu T,Zhang J,et A virus polymerase:An attractive target for next-generation anti-influenza therapeutics [J].DrugDiscovToday,2018,23(3):503-18.
[15] Dai J P,Wu L Q,Li R,et of 23-(s)-2-amino-3-phenylpropanoyl-silybin as an antiviral agent for influenza A virus infectioninvitroandinvivo[J].AntimicrobAgentsChemother,2013,57(9):4433-43.
[16] Jin Y H,Kwon S,Choi J G,et from melia fructus suppresses influenza A virus infection by altering nuclear localization of viral polymerase PA protein [J].FrontPharmacol,2019,10:1025.
[17] Hui D S,Lee N,Chan P K,et al.The role of adjuvant immunomodulatory agents for treatment of severe influenza [J].AntiviralRes,2018,150:202-16.
[18] Xie Y,Sun H X,Li d improves the immunogenicity of newcastle disease virus-based recombinant avian influenza vaccine in mice [J].ChemBiodivers,2010,7(3):677-89.
[19] Gasparini R,Amicizia D,Lai P L,et with anti-influenza activity:Present and future of strategies for the optimal treatment and management of II:Future compounds against influenza virus [J].JPrevMedHyg,2014,55(4):109-29.
[20] Geng Z K,Li Y Q,Cui Q H,et of the mechanisms of Ge Gen Decoction against influenza A virus infection [J].ChinJNatMed,2019,17(9):650-62.
[21] Liu X,Ai F,Li H,et effects of Shenfu injection against acute lung injury through inhibiting HMGB1-NF-κB pathway in a rat model of endotoxin shock [J].EvidBasedComplementAlternatMed,2019,2019:.
[22] Jang Y,Shin J S,Yoon Y S,et inhibits influenza virus infection by disrupting endosomal acidification and viral matrix protein 2 function [J].JVirol,2018,92(24):e01441-18.
[23] Mifsud E J,Tilmanis D,Oh D Y,et of ferrets with nitazoxanide and oseltamivir combinations is more effective at reducing the impact of influenza a virus infection compared to oseltamivir monotherapy [J].AntiviralRes,2020,176:.
[24] Furushima D,Ide K,Yamada H.Effect of tea catechins on influenza infection and the common cold with a focus on epidemiological/clinical studies [J].Molecules,2018,23(7):1795.
[25] Richart S M,Li Y L,Mizushina Y,et effect of curcumin and its structural analogue (Monoacetylcurcumin) on anti-influenza virus infection [J].JFoodDrugAnal,2018,26(3):1015-23.
[26] Li S W,Yang T C,Lai C C,et activity of aloe-emodin against influenza A virus via galectin-3 up-regulation [J].EurJPharmacol,2014,738:125-32.
[27] Liu W,Wang H,Zhu B,et al.An activity-integrated strategy of the identification,screening and determination of potential neuraminidase inhibitors from Radix Scutellariae [J].PloSone,2017,12(5):e0.
[28] 杨子峰,王玉涛,秦 笙,等.板蓝根水提物S-03体外抑制甲、乙型流感病毒感染的实验研究 [J].病毒学报,2011,27(3):218-23.
文章来源:《中国生化药物杂志》 网址: http://www.zgshywzz.cn/qikandaodu/2021/0730/667.html
上一篇:小鼠血液生理生化指标测定
下一篇:及其联用技术在化药中药及中成药中的应用进展